Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

China Pharmaceutical Industry Examined in New Report

Published: Monday, July 22, 2013
Last Updated: Monday, July 22, 2013
Bookmark and Share
Forecast suggests ASD 200 billion market by 2020.

New research report “Pharmaceutical Industry China Q2 2013 - An In Depth Analysis of Multinational and Chinese Biopharma Companies, Industry Trends, Environment, Regulation, Market Drivers, Restraints, Opportunities & Challenges” worked out by Kelly Scientific Publications has been recently published by Market Publishers Ltd. According to the study, China’s pharmaceutical market is forecast to be valued at approximately USD 200 billion by 2020.

In 2011, China’s pharmaceutical market was evaluated at around USD 40 billion. Currently, the country ranks as the third largest pharmaceutical market in the world and is also recognized as the main hub for Asian markets. The market growth is fueled by the increasing prevalence of chronic diseases in China, with a total of more than 250 million cases as of today. The production of generic drugs and vaccines represent the key sectors of the Chinese pharmaceutical market.

China’s pharmaceutical market is predicted to experience skyrocketing growth in the coming years, and will reach a value of approximately USD 200 billion by 2020. Diabetic drug annual sales are expected to exceed USD 2 billion in 2019. The Chinese oncology sector is likely to go beyond USD 2.19 billion by 2017.

The report provides a comprehensive guide to the Chinese pharmaceuticals market. It characterizes the country’s business environment, discloses critical data on the industry’s performance, traces prevailing industry trends and presents an all-round market assessment by therapeutic area. The study contains a SWOT analysis, an examination of the regulative landscape, and insights into the Chinese pharmaceutical export market. The report delves into the competitive landscape and grants access to the detailed profiles of the foreign and domestic companies operating in the market. Discussions of the important industry issues along with forecast projections and future growth rates are available in the research study.

Report Scope:

•        Chronic disease prevalence statistics for China.
•        Accurate description of the country’s business environment.
•        In-depth analysis of the Chinese pharmaceutical market.
•        Comprehensive market assessment by product type.
•        Details on the regulative landscape and novel drug developments.
•        Insights into China’s pharmaceutical export market.
•        Profiles of the leading multinational and domestic companies operating in the country-market.
•        Examination of the major factors driving and restraining the market growth.
•        Identification of the main market challenges and opportunities.
•        Discussion of the important industry issues.
•        Chinese pharmaceutical market forecast through 2020.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
Searching Big Data Faster
Theoretical analysis could expand applications of accelerated searching in biology, other fields.
Growing Hepatitis C in the Lab
Recent discovery allows study of naturally occurring forms of hepatitis C virus (HCV) in the lab.
Inciting an Immune Attack on Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
Reprogramming Cancer Cells
Researchers on Mayo Clinic’s Florida campus have discovered a way to potentially reprogram cancer cells back to normalcy.
Genetic Overlapping in Multiple Autoimmune Diseases May Suggest Common Therapies
CHOP genomics expert leads analysis of genetic architecture, with eye on repurposing existing drugs.
Surprising Mechanism Behind Antibiotic-Resistant Bacteria Uncovered
Now, scientists at TSRI have discovered that the important human pathogen Staphylococcus aureus, develops resistance to this drug by “switching on” a previously uncharacterized set of genes.
How DNA ‘Proofreader’ Proteins Pick and Edit Their Reading Material
Researchers from North Carolina State University and the University of North Carolina at Chapel Hill have discovered how two important proofreader proteins know where to look for errors during DNA replication and how they work together to signal the body’s repair mechanism.
Fat in the Family?
Study could lead to therapeutics that boost metabolism.
Tissue Bank Pays Dividends for Brain Cancer Research
Checking what’s in the bank – the Brisbane Breast Bank, that is – has paid dividends for UQ cancer researchers.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!